POLR3A Gene Leukodystrophy hypomyelinating type 7 NGS Genetic Test
Short Name: POLR3A Leukodystrophy Type 7 NGS Test
Also known as: POLR3A Gene Test, Hypomyelinating Leukodystrophy Type 7 Genetic Test, POLR3A Leukodystrophy NGS Panel
POLR3A Gene Leukodystrophy hypomyelinating type 7 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Samples are processed on receipt; reports are issued within 3 to 4 weeks. The report includes clinical interpretation and raw data files.. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr SULOCHANA HEMCHANDRA HOLLA
Consultant Medical Geneticist · Reg: 8532
Last reviewed: September 7, 2026
Overview
The purpose of this test is to sequence the POLR3A gene and identify clinically significant variants that may explain signs and symptoms of hypomyelinating leukodystrophy type 7. The result helps clinicians make a molecular diagnosis, guide surveillance and management, and provide accurate inheritance and recurrence-risk counselling.
- Test Code
- 4198
- Price
- ₹20,000
- Sample Type
- Blood or Extracted DNA or One drop Blood on FTA Card
- Result Time
- Samples are processed on receipt; reports are issued within 3 to 4 weeks. The report includes clinical interpretation and raw data files.
- Fasting Required
- No
- Method
- Next-Generation Sequencing (NGS)
Sample Collection
No fasting is required. Please provide the referring physician's clinical notes, pedigree chart, MRI/EEG reports, and any previous genetic test results.
Method: Blood draw by phlebotomist, FTA card blood spot, or extracted DNA submission
Laboratory Analysis
A small blood sample will be collected in an EDTA tube, or a blood spot will be placed on an FTA card depending on the method chosen.
Report Delivery
No special precautions are needed. The sample should be transported to the laboratory according to the provided instructions.
Timeline: Samples are processed on receipt; reports are issued within 3 to 4 weeks. The report includes clinical interpretation and raw data files.
Patient Instructions
About This Test
Who Should Get This Test
The purpose of this test is to sequence the POLR3A gene and identify clinically significant variants that may explain signs and symptoms of hypomyelinating leukodystrophy type 7. The result helps clinicians make a molecular diagnosis, guide surveillance and management, and provide accurate inheritance and recurrence-risk counselling.
How to Prepare
- For blood sample: use EDTA vacutainer and mix gently.
- For FTA card: apply one drop of blood to each marked circle and air-dry.
- For extracted DNA: submit the minimum quantity specified by the laboratory.
- Label the sample clearly with patient name, date of collection, and contact number.
Doctor's Notes
Reviewed by Dr SULOCHANA HEMCHANDRA HOLLA — MBBS, MD (Medical Genetics) · Reg. No. 8532
"Genetic confirmation is important in suspected leukodystrophy because symptoms overlap with other white matter disorders. A definitive molecular diagnosis enables accurate counselling, prognosis, and family risk assessment."
Last medically reviewed: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Insufficient blood or DNA quantity
- Clotted or haemolysed blood sample
- Mislabeled sample
- Sample not accompanied by consent or clinical requisition
Understanding Your Results
If you receive a positive, uncertain, or negative test result but still have clinical signs of leukodystrophy, please discuss the result with your referring neurologist or clinical geneticist before making any treatment or reproductive decisions.
Limitations
- ⚠The test is specific to POLR3A; variants in other leukodystrophy genes will not be detected.
- ⚠NGS may not reliably detect large deletions/duplications, structural rearrangements, deep intronic variants, or repeat expansions.
- ⚠Variants of uncertain significance may be reported; additional studies may be needed.
- ⚠A negative result does not rule out all genetic or non-genetic causes of hypomyelination.
Risks & Considerations
- ●Minimal pain or bruising at the blood collection site
- ●No significant risk with FTA card collection
- ●No radiation exposure or contrast agent is used
Interfering Factors
- ●Blood transfusion within 2 weeks may cause DNA mixture; if possible, collect sample before transfusion.
- ●Recent bone marrow transplantation may confound result interpretation.
- ●Poor sample quality, low DNA yield, or degradation can lead to insufficient coverage.
- ●Mislabeling or sample mix-up can cause an incorrect result.
Compare With Similar Tests
| Test | POLR3A Gene Leukodystrophy hypomyelinating type 7 NGS Genetic Test | |||
|---|---|---|---|---|
| Comparison | POLR3A Gene Leukodystrophy hypomyelinating type 7 NGS Genetic Test |
Frequently Asked Questions
What is the POLR3A gene leukodystrophy type 7 NGS genetic test?
What sample do I need to provide?
Is fasting required before the test?
Who should take this test?
How long will the report take?
What is the cost of the test?
Why does DNA Labs India provide FASTQ and VCF files?
What variants can this test detect?
What does a variant of uncertain significance (VUS) mean?
Can this test be used for prenatal diagnosis?
Is home sample collection available?
What should I do if the test result is negative?
Related Tests
Angelman Syndrome Test
₹10,000Duchenne / Becker Muscular Dystrophy (DMD / BMD) Gene Mutation Test
₹14,000Episodic Ataxia Type 1 Hotspot Test
₹11,500Episodic Ataxia Comprehensive Profile Hotspot Test
₹16,000Megalencephalic Leukoencephalopathy with Subcortical Cysts Van Der Knaap and Nalband MLC Gene Hotspot Mutation Test
₹7,500Analyzer 18 SMA 18 Test Panel
₹1,755Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.
